The Harvard Drug Group recalls 28mg Memantine Hydrochloride Extended-release Capsules due to failed dissolution specifications observed in stability studies. This may affect medication effectiveness.
“Memantine Capsules Recall: Failed Dissolution Specifications Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37656-memantine-capsules-recall-failed-dissolution-specifications-risk. Based on FDA recall #D-0844-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0844-2020%22&limit=1).
The Harvard Drug Group recalled Memantine Hydrochloride Extended-release Capsules, 28mg, due to failed dissolution specifications, the FDA said on Dec. 13, 2019. The recall involves 246 cartons distributed nationwide and is classified as Class III.
The recall was issued because high out-of-specification results were observed at stability studies for the capsules. The FDA classified this as a Class III recall.
Context
GovInfoNow's records show The Harvard Drug Group has 20 other recalls on record since July 15, 2016. Other recent recalls include Harvard Drug Group Recalls Tramadol Tablets Due to Packaging Defect (June 16, 2023) and Harvard Drug Group Recalls Gabapentin Tablets Due to Foreign Tablet Mixup (April 24, 2023). Similar recent recalls of similar products include Harvard Drug Group Memantine Capsules Recall: Failed Dissolution Specifications (March 24, 2026), AvKARE Amantadine Capsules Recall: Failed Dissolution Specifications (Feb. 13, 2026), and Sun Pharmaceutical Lisdexamfetamine Capsules Recall: Failed Dissolution Test (Oct. 28, 2025).
How to tell if you have this one
Check for Memantine Hydrochloride Extended-release Capsules 28mg in 100-count Unit Dose Cartons. The product was manufactured by Lupin Pharmaceuticals and distributed by Major Pharmaceuticals. Lot number M02465D is associated with this recall.
Brand
The Harvard Drug Group
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for the product name, strength (28mg), and packaging (100-count Unit Dose Cartons) to confirm if it matches the recalled item.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “U.S.A. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 11 months after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0844-2020 (December 13, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0844-2020 to see it in context.
Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.